Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Le Gallo

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Gene Medicine|March 15, 2008
Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5Matthieu Le Gallo, Olivier Toutirais, Tristan Montier, et al.
BMC Research Notes|June 22, 2018
Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cellsMatthieu Le Gallo, Thibault de la Motte Rouge, Amanda Poissonnier, et al.
Iscience|October 4, 2021
SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19Sophie Martin, Christopher Heslan, Gwénaële Jégou, et al.
EMBO Reports|February 22, 2024
IRE1 RNase controls CD95-mediated cell deathDiana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, et al.
European Journal of Immunology|May 1, 2009
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cellsOlivier Toutirais, Florian Cabillic, Gaëlle Le Friec, et al.
Cancer|September 24, 2017
The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomasMatthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, et al.
The FEBS Journal|January 25, 2023
Metalloprotease-mediated cleavage of CD95 ligandVesna Risso, Mélissa Thomas, Blandine Guével, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2007
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomasFrancoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais, et al.
Nature Communications|May 6, 2022
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancerAitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Molecular Cancer Research : MCR|September 21, 2019
Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian CancerThibault De La Motte Rouge, Julien Corné, Aurélie Cauchois, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Gene Medicine|March 15, 2008
Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5Matthieu Le Gallo, Olivier Toutirais, Tristan Montier, et al.
BMC Research Notes|June 22, 2018
Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cellsMatthieu Le Gallo, Thibault de la Motte Rouge, Amanda Poissonnier, et al.
Iscience|October 4, 2021
SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19Sophie Martin, Christopher Heslan, Gwénaële Jégou, et al.
EMBO Reports|February 22, 2024
IRE1 RNase controls CD95-mediated cell deathDiana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, et al.
European Journal of Immunology|May 1, 2009
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cellsOlivier Toutirais, Florian Cabillic, Gaëlle Le Friec, et al.
Cancer|September 24, 2017
The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomasMatthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, et al.
The FEBS Journal|January 25, 2023
Metalloprotease-mediated cleavage of CD95 ligandVesna Risso, Mélissa Thomas, Blandine Guével, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2007
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomasFrancoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais, et al.
Nature Communications|May 6, 2022
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancerAitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Molecular Cancer Research : MCR|September 21, 2019
Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian CancerThibault De La Motte Rouge, Julien Corné, Aurélie Cauchois, et al.
Pageof 4